Bearish signal on daily chart
Company announced a dividend of Rs 475.0 per share on May 15, 2025 with record date of Jul 25, 2025.
Potential
Upside
1 Year
Target
STRONG BUY
Mean Recos by
6 Analysts
0
0
0
2
4
Strong Sell
Sell
Hold
Buy
Strong Buy
/10
Stock Score
Earnings | |
Fundamentals | |
Relative Valuation | |
Risk | |
Price Momentum |
Company announced a dividend of Rs 475.0 per share on May 15, 2025 with record date of Jul 25, 2025.
Company has no debt since last 5 years. (Source: Standalone Financials)
Company has spent less than 1% of its operating revenues towards interest expenses and 9.17% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)
14 day moving crossover appeared on Jul 18, 2025. Average price decline of -1.85% within 7 days of this signal in last 5 years.
Abbott India Ltd. share price moved down by -0.12% from its previous close of Rs 34,165.00. Abbott India Ltd. stock last traded price is 34,125.00
Share Price | Value |
---|---|
Today/Current/Last | 34,125.0034,183.35 |
Previous Day | 34,165.0034,128.35 |
Do you find these insights useful?
hate it
meh
love it
PE Ratio (x) | 51.27 | ||||||||||
EPS - TTM (₹) | 665.64 | ||||||||||
MCap (₹ Cr.) | 72,513.24 | ||||||||||
Sectoral MCap Rank | 9 | ||||||||||
PB Ratio (x) | 17.15 | ||||||||||
Div Yield (%) | 1.39 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| 0.58 | ||||||||||
VWAP (₹) | 34,104.71 | ||||||||||
52W H/L (₹)BV/Share (₹)MCap/Sales |
|
PE Ratio (x) | 51.35 | ||||||||||
EPS - TTM (₹) | 665.64 | ||||||||||
MCap (₹ Cr.) | 72,637.23 | ||||||||||
Sectoral MCap Rank | 9 | ||||||||||
PB Ratio (x) | 17.11 | ||||||||||
Div Yield (%) | 1.39 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| 0.56 | ||||||||||
VWAP (₹) | 34,057.90 | ||||||||||
52W H/L (₹)BV/Share (₹)MCap/Sales |
|
PE Ratio (x) | 51.27 | ||||||||||
EPS - TTM (₹) | 665.64 | ||||||||||
Dividend Yield (%) | 1.39 | ||||||||||
VWAP (₹) | 34,104.71 | ||||||||||
PB Ratio (x) | 17.15 | ||||||||||
MCap (₹ Cr.) | 72,513.24 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
BV/Share (₹) | 1,992.14 | ||||||||||
Sectoral MCap Rank | 9 | ||||||||||
52W H/L (₹) | 37,000.00 / 25,325.00 | ||||||||||
Beta Beta
| 0.58 | ||||||||||
MCap/Sales | 10.19 |
PE Ratio (x) | 51.35 | ||||||||||
EPS - TTM (₹) | 665.64 | ||||||||||
Dividend Yield (%) | 1.39 | ||||||||||
VWAP (₹) | 34,057.90 | ||||||||||
PB Ratio (x) | 17.11 | ||||||||||
MCap (₹ Cr.) | 72,637.23 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
BV/Share (₹) | 1,992.14 | ||||||||||
Sectoral MCap Rank | 9 | ||||||||||
52W H/L (₹) | 35,921.55 / 25,260.20 | ||||||||||
Beta Beta
| 0.56 | ||||||||||
MCap/Sales | 10.19 |
1 Day | -0.12% |
1 Week | -0.86% |
1 Month | 8.11% |
3 Months | 11.19% |
1 Year | 18.51% |
3 Years | 71.76% |
5 Years | 123.58% |
1 Day | 0.16% |
1 Week | -0.66% |
1 Month | 8.49% |
3 Months | 11.41% |
1 Year | 18.77% |
3 Years | 72.14% |
5 Years | 123.99% |
Check whether Abbott India belongs to analysts' top-rated companies list?
View Stock ScreenersCurrent
Mean Recos by 6 Analysts
Ratings | Current | 1 Week Ago | 1 Month Ago | 3 Months Ago |
---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 3 |
Buy | 2 | 2 | 2 | 2 |
Hold | - | - | - | - |
Sell | - | - | - | - |
Strong Sell | - | - | - | - |
# Analysts | 6 | 6 | 6 | 5 |
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 9.17% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)Quarterly | Annual | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|---|
Total Income | 1,680.61 | 1,686.03 | 1,693.15 | 1,624.94 | 1,519.78 |
Total Income Growth (%) | -0.32 | -0.42 | 4.20 | 6.92 | 1.81 |
Total Expenses | 1,193.98 | 1,196.18 | 1,211.22 | 1,184.97 | 1,127.29 |
Total Expenses Growth (%) | -0.18 | -1.24 | 2.22 | 5.12 | 5.61 |
EBIT | 486.63 | 489.85 | 481.93 | 439.97 | 392.49 |
EBIT Growth (%) | -0.66 | 1.64 | 9.54 | 12.10 | -7.72 |
Profit after Tax (PAT) | 367.04 | 360.78 | 358.61 | 328.01 | 287.06 |
PAT Growth (%) | 1.74 | 0.61 | 9.33 | 14.27 | -7.69 |
EBIT Margin (%) | 28.96 | 29.05 | 28.46 | 27.08 | 25.83 |
Net Profit Margin (%) | 21.84 | 21.40 | 21.18 | 20.19 | 18.89 |
Basic EPS (₹) | 172.72 | 169.78 | 168.76 | 154.36 | 135.09 |
Quarterly | Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Total Revenue | 6,684.73 | 6,097.18 | 5,502.88 | 4,996.48 | 4,390.92 |
Total Revenue Growth (%) | 9.64 | 10.80 | 10.14 | 13.79 | 4.36 |
Total Expenses | 4,797.78 | 4,479.43 | 4,229.06 | 3,916.75 | 3,464.97 |
Total Expenses Growth (%) | 7.11 | 5.92 | 7.97 | 13.04 | 1.77 |
Profit after Tax (PAT) | 1,414.44 | 1,201.22 | 949.41 | 798.70 | 690.69 |
PAT Growth (%) | 17.75 | 26.52 | 18.87 | 15.64 | 16.49 |
Operating Profit Margin (%) | 29.61 | 27.87 | 24.11 | 22.33 | 21.90 |
Net Profit Margin (%) | 22.06 | 20.53 | 17.75 | 16.23 | 16.02 |
Basic EPS (₹) | 665.62 | 565.28 | 446.78 | 375.86 | 325.04 |
All figures in Rs Cr, unless mentioned otherwise
No reported Profit & Loss Statement are available.
Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Total Assets | 5,917.31 | 5,193.49 | 4,555.51 | 4,224.12 | 3,840.45 |
Total Assets Growth (%) | 13.94 | 14.00 | 7.85 | 9.99 | 8.28 |
Total Liabilities | 1,684.16 | 1,494.60 | 1,366.97 | 1,404.33 | 1,238.29 |
Total Liabilities Growth (%) | 12.68 | 9.34 | -2.66 | 13.41 | 11.04 |
Total Equity | 4,233.15 | 3,698.89 | 3,188.54 | 2,819.79 | 2,602.16 |
Total Equity Growth (%) | 14.44 | 16.01 | 13.08 | 8.36 | 7.01 |
Current Ratio (x) | 3.39 | 2.42 | 2.51 | 3.20 | 3.41 |
Total Debt to Equity (x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Contingent Liabilities | 0.00 | 106.52 | 106.06 | 123.78 | 123.51 |
All figures in Rs Cr, unless mentioned otherwise
No reported Balance Sheet are available.
Cash from Operations vs PAT
Operating cash flow of Rs 1011.84 cr is 0.72 times compared to the reported net profit of Rs 1414.44 cr. (Source: Standalone Financials)Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Net Cash flow from Operating Activities | 1,011.84 | 1,212.81 | 893.39 | 947.66 | 726.74 |
Net Cash used in Investing Activities | 182.18 | -416.03 | -147.71 | -395.84 | -71.82 |
Net Cash flow from Financing Activities | -925.17 | -744.71 | -638.72 | -637.38 | -581.79 |
Net Cash Flow | 268.85 | 52.07 | 106.96 | -85.56 | 73.13 |
Closing Cash & Cash Equivalent | 560.59 | 291.74 | 239.67 | 132.71 | 218.27 |
Closing Cash & Cash Equivalent Growth (%) | 92.15 | 21.73 | 80.60 | -39.20 | 50.39 |
Total Debt/ CFO (x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
All figures in Rs Cr, unless mentioned otherwise
No reported Cash Flow Statement are available.
Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Return on Equity (%) | 33.41 | 32.47 | 29.77 | 28.32 | 26.54 |
Return on Capital Employed (%) | 42.09 | 42.33 | 38.50 | 36.37 | 33.60 |
Return on Assets (%) | 23.90 | 23.12 | 20.84 | 18.90 | 17.98 |
Interest Coverage Ratio (x) | 172.37 | 136.66 | 85.04 | 60.99 | 51.65 |
Asset Turnover Ratio (x) | 1.15 | 1.20 | 1.22 | 1.22 | 112.22 |
Price to Earnings (x) | 46.30 | 47.85 | 49.50 | 47.17 | 46.30 |
Price to Book (x) | 15.43 | 15.48 | 14.72 | 13.34 | 12.24 |
EV/EBITDA (x) | 32.32 | 32.40 | 33.09 | 29.93 | 29.37 |
EBITDA Margin (%) | 30.74 | 29.08 | 25.42 | 23.68 | 23.25 |
No reported Financial Ratios are available.
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 9.17% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)
Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)
Cash from Operations vs PAT
Operating cash flow of Rs 1011.84 cr is 0.72 times compared to the reported net profit of Rs 1414.44 cr. (Source: Standalone Financials)
Do you find these insights useful?
hate it
meh
love it
Bullish / Bearish signals for Abbott India basis selected technical indicators and moving average crossovers.
14 Day EMA Crossover
Bearish signal on daily chart
Appeared on: 18 Jul 2025
14D EMA: 34128.87
Date | 7 days Gain/Loss % |
---|---|
23 Jun 2025 | 0.16% |
19 Jun 2025 | -1.35% |
26 May 2025 | -0.73% |
8 May 2025 | -1.50% |
Average price decline of -1.83% within 7 days of Bearish signal in last 5 years
R1 | R2 | R3 | PIVOT | S1 | S2 | S3 | |
---|---|---|---|---|---|---|---|
Classic | 34373.33 | 34621.67 | 35101.67 | 34141.67 | 33893.33 | 33661.67 | 33181.67 |
5 DAYS | 14 DAYS | 28 DAYS | |
---|---|---|---|
ATR | 583.75 | 786.78 | 803.25 |
Choose from Peers
Choose from Stocks
NAME | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|
Abbott India Stock Performance | -0.12 | -0.86 | 8.11 | 11.19 | 18.51 | 71.76 | 123.58 |
GSK Pharma Stock Performance | -1.11 | -3.25 | -4.50 | 7.97 | 22.42 | 107.51 | 106.58 |
Pfizer Stock Performance | -0.80 | -3.58 | -8.17 | 27.74 | 4.63 | 27.50 | 28.72 |
AstraZeneca Stock Performance | -2.93 | -1.33 | -6.32 | 4.26 | 41.33 | 198.06 | 170.29 |
Sanofi India Stock Performance | -0.36 | 0.68 | -1.77 | -4.35 | -6.21 | -10.36 | -23.33 |
Add More |
Choose from Peers
Choose from Stocks
NAME | P/E (x) | P/B (x) | ROE % | ROCE % | ROA % | Rev CAGR [3Yr] | OPM | NPM | Basic EPS | Current Ratio | Total Debt/ Equity (x) | Total Debt/ CFO (x) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbott India | 51.27 | 17.13 | 33.41 | 42.09 | 23.90 | 10.08 | 29.61 | 22.06 | 665.62 | 3.39 | 0.00 | 0.00 |
GSK Pharma | 57.32 | 27.25 | 47.67 | 57.03 | 22.64 | 5.06 | 33.51 | 24.74 | 54.52 | 1.79 | 0.00 | 0.00 |
Pfizer | 31.70 | 27.01 | 33.24 | 22.93 | 27.21 | -2.79 | 28.27 | 40.85 | 100.38 | 5.04 | 0.00 | 0.00 |
AstraZeneca | 196.97 | 29.59 | 15.02 | 31.23 | 7.62 | 28.57 | 14.83 | 6.74 | 46.30 | 1.91 | 0.00 | 0.00 |
Sanofi India | 34.59 | 15.93 | 48.02 | 52.72 | 25.64 | -12.39 | 23.37 | 20.52 | 179.46 | 1.57 | 0.00 | 0.00 |
Add More |
Choose from Peers
Choose from Stocks
Do you find these insights useful?
hate it
meh
love it
Category | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Promoters | 74.99 | 74.99 | 74.99 | 74.99 |
Pledge | 0.00 | 0.00 | 0.00 | 0.00 |
FII | 0.16 | 0.16 | 0.17 | 0.17 |
DII | 9.16 | 8.89 | 8.94 | 8.93 |
Mutual Funds | 7.77 | 7.73 | 7.77 | 7.69 |
Others | 15.69 | 15.96 | 15.90 | 15.90 |
Category | No. of Shares | Percentage | % Change QoQ |
---|---|---|---|
Promoters | 1,59,34,048 | 74.99 % | 0.00 |
Pledge | 0 | 0.00 % | 0.00 |
FII | 34,602 | 0.16 % | 0.00 |
DII | 19,47,247 | 9.16 % | 0.26 |
MF | 16,51,415 | 7.77 % | 0.03 |
Others | 33,33,405 | 15.69 % | -0.26 |
980.49
Amount Invested (in Cr.)
2.96838054%
% of AUM
0.00
% Change (MoM basis)
592.28
Amount Invested (in Cr.)
1.84690563%
% of AUM
0.00
% Change (MoM basis)
520.68
Amount Invested (in Cr.)
1.99%
% of AUM
0.00
% Change (MoM basis)
MF Ownership as on 30 June 2025
Meeting Date | Announced on | Purpose | Details |
---|---|---|---|
Aug 13, 2025 | May 15, 2025 | AGM | - |
May 15, 2025 | May 07, 2025 | Board Meeting | Audited Results & Final Dividend |
Feb 05, 2025 | Jan 28, 2025 | Board Meeting | Quarterly Results |
Nov 07, 2024 | Oct 28, 2024 | Board Meeting | Quarterly Results |
Aug 08, 2024 | May 09, 2024 | AGM | - |
Type | Dividend | Dividend per Share | Ex-Dividend Date | Announced on |
---|---|---|---|---|
Final | 4750% | 475.0 | Jul 25, 2025 | May 15, 2025 |
Final | 4100% | 410.0 | Jul 19, 2024 | May 09, 2024 |
Special | 1450% | 145.0 | Jul 21, 2023 | May 20, 2023 |
Final | 1800% | 180.0 | Jul 21, 2023 | May 19, 2023 |
Special | 1300% | 130.0 | Aug 02, 2022 | May 18, 2022 |
All Types | Ex-Date | Record Date | Announced on | Details |
---|---|---|---|---|
Bonus | Aug 17, 1998 | Sep 20, 1998 | Aug 10, 1998 | Bonus Ratio: 1 share(s) for every 1 shares held |
Rights | - | - | Feb 02, 1994 | Rights ratio: 1 share for every 10 held at a price of Rs 15.0 |
Bonus | - | - | Jun 22, 1988 | Bonus Ratio: 1 share(s) for every 1 shares held |
Bonus | - | Jul 28, 1987 | Feb 02, 1987 | Bonus Ratio: 1 share(s) for every 1 shares held |
Bonus | - | - | Jun 22, 1984 | Bonus Ratio: 3 share(s) for every 5 shares held |
Abbott India Ltd., incorporated in the year 1944, is a Large Cap company (having a market cap of Rs 72,513.24 Crore) operating in Pharmaceuticals sector. Abbott India Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Scrap and Export Incentives for the year ending 31-Mar-2024.For the quarter ended 31-03-2025, the company has reported a Standalone Total Income of Rs 1,680.61 Crore, down .32 % from last quarter Total Income of Rs 1,686.03 Crore and up 10.58 % from last year same quarter Total Income of Rs 1,519.78 Crore. Company has reported net profit after tax of Rs 367.04 Crore in latest quarter.The company’s top management includes Mr.Munir Shaikh, Ms.Swati Dalal, Mr.Ambati Venu, Mr.Kaiyomarz Marfatia, Mr.Mahadeo Karnik, Mr.Sabina Ewing, Ms.Anisha Motwani, Ms.Shalini Kamath, Mr.Sudarshan Jain, Mr.Sridhar Kadangode, Ms.Sangeeta Shetty. Company has SRBC & Co LLP as its auditors. As on 30-06-2025, the company has a total of 2.12 Crore shares outstanding.Abbott India Share Price Today is Rs. 34125.00. On previous day, the Abbott India Share Price (NSE) closed at Rs. 34165.0, featuring among the most traded securities on the National Stock Exchange.
Shareholdings:
As of 30th Jun, 2025, the promoter held 74.99% of the stake in Abbott India shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Abbott India stocks was 0.16% as compared to 0.17% in Mar 2025 with decrease of 0.01%. The domestic institutional investors (DII) holdings on 30th Jun, 2025 was 8.89% as compared to 8.94% in Mar 2025 with decrease of 0.05%. Out of the total DII holdings in Abbott India shares 7.73% was held by mutual funds. The rest including public held is 15.96%. Abbott India stock price is reflected on both the exchanges - BSE and NSE.
Dividend, Bonus & Split Information:
Abbott India Dividend: Ever since 1944, Abbott India dividends has been paid out around 36 times. As on 18 Jul, 2025, 03:55 PM IST, The overall dividend yield for Abbott India stands at 1.39%. The last dividend paid was on July 25, 2025 (Rs. 475.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2025 is Rs. 665.64.
Abbott India Bonus: The most recent bonus issue had been in year August 17, 1998 around 26 years ago at 1 : 1 ratio. The first bonus issue was announced in Jun 1969.
Stock Forecast:
After showing 1680.61 Cr. of sales and 0.32% of quarterly net loss, there have been multiple ups and downs in the Abbott India stock prices in the past few weeks. For example, Abbott India stock price on 11th of July 2025 was around Rs. 34420.0. Abbott India share price now stands at an average of Rs. 34125.00. Judging by last week's performance, stock is in down trend.
Abbott India has a median target price of Rs. 35341.6 in 12 months by 5 analysts. They have provided a high estimate of Rs. 40128.0 and low estimate of Rs. 30330.0 for Abbott India share.
Historical Prices and Performance:
Abbott India, incorporated in 1944 is a Large Cap company (with a market cap of Rs. 72598.24) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Abbott India stock was 33.41%, 32.47%, 29.77%, 28.32% and 26.54% respectively.
The Abbott India share gave a 3 year return of 73.01% as compared to Nifty 50 which gave a return of 56.47%.
Abbott India announced 4750.0% final dividend on July 25, 2025.
Key Metrics:
PE Ratio of Abbott India is 51.33
Prices/Sales Ratio of Abbott India is 10.19
Price/Book Ratio of Abbott India is 17.15
Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Abbott India, major competitors and peers include GSK Pharma, Pfizer, AstraZeneca and Sanofi India. As of Mar 2025, the dividend yield of Abbott India stands at 1.39% while GSK Pharma, Pfizer, AstraZeneca and Sanofi India stand at 1.72%, 3.1%, 0.35% and 1.97% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 51.33 and 17.15 respectively.
Leadership of Abbott India :
Sangeeta Shetty is Co. Secretary & Compl. Officer
Sridhar Kadangode is Chief Financial Officer
Munir Shaikh is Chairman
Swati Dalal is Managing Director
Kaiyomarz Marfatia is Non Executive Director
Ambati Venu is Non Executive Director
Sabina Ewing is Non Executive Director
Mahadeo Karnik is Non Executive Director
Anisha Motwani is Independent Director
Shalini Kamath is Independent Director
Sudarshan Jain is Independent Director
Show More
Munir Shaikh
ChairmanSwati Dalal
Managing DirectorAmbati Venu
Non Executive DirectorKaiyomarz Marfatia
Non Executive DirectorMahadeo Karnik
Non Executive DirectorSabina Ewing
Non Executive DirectorAnisha Motwani
Independent DirectorShalini Kamath
Independent DirectorSudarshan Jain
Independent DirectorSridhar Kadangode
Chief Financial OfficerSangeeta Shetty
Co. Secretary & Compl. OfficerIndustry
Key Indices Listed on
Nifty 500, BSE 500, Nifty Pharma, + 25 more
Address
3, Corporate Park,Sion-Trombay Road,Mumbai, Maharashtra - 400071
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.